Emgality

Emgality is a prescription medication used to prevent migraines in adults. It contains a protein called galcanezumab that targets a substance in the body called calcitonin gene-related peptide (CGRP), which is involved in migraine development. By blocking CGRP, Emgality helps reduce how often migraines occur and their intensity. It is administered as a monthly injection, making it convenient for ongoing migraine prevention. Emgality is generally well-tolerated and can improve quality of life for individuals who experience frequent migraines, allowing them to manage their condition more effectively.